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Abstract
Expanded genetic code approaches are a powerful means to add new and useful chemistry
to proteins at defined residues positions. One such use is the introduction of non-biological
reactive chemical handles for site-specific biocompatible orthogonal conjugation of pro-
teins. Due to our currently limited information on the impact of non-canonical amino acids
(nAAs) on the protein structure-function relationship, rational protein engineering is a “hit
and miss” approach to selecting suitable sites. Furthermore, dogma suggests surface ex-
posed native residues should be the primary focus for introducing new conjugation chemis-
try. Here we describe a directed evolution approach to introduce and select for in-frame
codon replacement to facilitate engineering proteins with nAAs. To demonstrate the ap-
proach, the commonly reprogrammed amber stop codon (TAG) was randomly introduced
in-frame in two different proteins: the bionanotechnologically important cyt b562 and thera-
peutic protein KGF. The target protein is linked at the gene level to sfGFP via a TEV prote-
ase site. In absence of a nAA, an in-frame TAG will terminate translation resulting in a non-
fluorescent cell phenotype. In the presence of a nAA, TAG will encode for nAA incorporation
so instilling a green fluorescence phenotype on E. coli. The presence of endogenously ex-
pressed TEV proteases separates in vivo target protein from its fusion to sfGFP if expressed
as a soluble fusion product. Using this approach, we incorporated an azide reactive handle
and identified residue positions amenable to conjugation with a fluorescence dye via strain-
promoted azide-alkyne cycloaddition (SPAAC). Interestingly, best positions for efficient
conjugation via SPAAC were residues whose native side chain were buried through analy-
sis of their determined 3D structures and thus may not have been chosen through rational
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protein engineering. Molecular modeling suggests these buried native residues could be-
come partially exposed on substitution to the azide containing nAA.
Introduction
The advent of expanded genetic code approaches has allowed proteins to be engineered to con-
tain new chemistry not normally present in the natural amino acid repertoire (see [1–3] for re-
cent reviews). Through the use of reprogrammed codons or entirely new codon systems in
conjunction with engineered translation machinery, upwards of 100 non-canonical amino
acids (nAAs) can be incorporated into a wide range of cell types (from bacteria to mammalian)
and even whole organisms (e.g. Caenorhabditis elegans [4], Drosophila melanogaster [5] and
Arabidopsis thaliana [6]). Reprogrammed genetic code systems essentially makes any member
of the proteome, whether native or recombinant, accessible through defined and targeted nAA
incorporation during cellular protein synthesis. Furthermore, as proteins containing nAA be-
come more valuable in a commercial context, recombinant expression can generate high yields
of protein product for downstream applications [7, 8].
The most common expanded genetic code approach is to reprogramme the low usage
amber (TAG) stop codon [9, 10]. Reprogramming is implemented using engineered tRNA-
amino-acyl/tRNA synthase pairs that incorporate a desired nAA in response to the UAG
codon during cellular protein synthesis [2]. This approach has recently been further enhanced
through the development of new E. coli strains with all native TAG stop codons removed from
the genome along with it associated ribosomal release factor RF1 [11].
While protein engineering using nAAs is becoming more established it still suffers from the
drawback of traditional rational site-directed mutagenesis: limited understanding of the effect
of a nAA on protein structure and function leading to the use of a fairly rudimentary design
processes. As has been repeatedly observed during rational protein engineering (see reference
[12, 13] for two excellent recent examples), the impact of nAA incorporation at a particular site
may not always be obvious, and while our understanding of the effect of a particular nAA on
the protein folding-structure-function relationship is increasing [14–16] it is still very limited.
Directed evolution (see [17–19] for a sample of available reviews) was developed as a concept
to address the shortcomings in rational protein engineering by taking a Darwinian approach
through the generation of molecular diversity followed by library screening and selection. By
sampling the whole protein backbone variants with new or enhanced properties containing
non-intuitive mutations are routinely isolated.
Directed evolution approaches to widen nAA sampling were until recently restricted to
sampling defined regions [20]. The advent of transposon-based approaches that allowed ran-
dom trinucleotide/codon (TriNEx) mutations events across the length of a gene [21, 22]
opened up the opportunity for whole gene TAG sampling [23, 24]. This has proved useful in
identifying residues in proteins such as GFP not previously sampled by traditional mutagenesis
by which nAAs can modulate function [15]. The main problem with the basic approach was
the quality of the libraries generated due to the inherent nature of the method. Trinucleotide
exchange makes no allowance for codon positioning thus replacement may occur across two
adjacent codons generating an out of frame TAG replacement (Fig 1A). Additionally, the cas-
sette donating the TAG codon may insert in the wrong direction resulting in CTA codon inser-
tion. In some instances CTA codon sample may be useful in expanding sampling by rescuing
some cross codon replacement events where the last nucleotide of a codon is G (e.g. aaC TAg).
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One important area that would benefit from combining nAA incorporation and broad pro-
tein sampling is defined and bioorthogonal protein conjugation [1, 26]. Attachment of chemi-
cally useful adducts to proteins is important for applications ranging from bioimaging to
therapeutics. Traditionally, attachment has relied on utilising the inherent chemistry in a pro-
tein, normally amine, carboxyl or thiol groups. However, these groups are ubiquitous both
within an individual protein and the proteome as whole leading to non-specific, non-optimal
and in the case of complex biological mixtures targetless labelling. Thus the ability incorporate
a reactive handle into a desired position in protein without any native biological reactivity is of
great utility. Click chemistry [27], especially strain-promoted azide-alkyne cycloaddition
(SPAAC) [28, 29] is becoming of particular interest due to it speed and compatibility with bio-
logical systems. Incorporation of the phenyl azide Click handle into a protein via the nAA p-
azido-L-phenylalanine (azF) [30] makes Click chemistry a reality both in vivo and in situ [31].
However, little is known about the influence of residue microenvironment on azide reactivity
in SPAAC in terms of efficiency and kinetics. Recent work suggests that the link between sur-
face accessibility of the azide group and SPAAC is not straight forward and counter intuitive
[32].
The challenge of trinucleotide exchange is to quickly identify desired TAG mutations with-
out extensive sequencing and functional screening. Here we present a general approach that al-
lows the generation of in-frame TAG codons across a gene of interest. The method utilises
read-through of the target gene to superfolder GFP (sfGFP) [33] in the presence of a nAA. In
the absence of nAA, the TAG reverts to a stop codon so prematurely stopping translation in
the target gene before reaching the sfGFP segment. A TEV protease cleavage site is present be-
tween the target and sfGFP so that the activity of the two proteins can be decoupled soon after
Fig 1. In-frame TAG codon replacement. (A) Step 1 involves trinucleotide deletion followed by TAG
donation using a combination of the engineered transposon MuDel [25] and the DNA cassette SubSeq [21]
essentially as described previously [23] and outlined in B. The TAG substitution library is then cloned in front
of the TEV-sfGFP cassette in plasmid pIFtag (S1 Fig). Step 2 outlines the selection for in-frame TAG
substitutions. Initially, cells are grown in the absence of a nAA and non-fluorescent colonies selected;
fluorescent colonies are removed at this stage as they are deemed not to have an in-frame TAG due to the
generation of a full translation product. The second selection involves plating the selected colonies in the
presence of nAA. Those cells that regain fluorescence suppress TAG termination due to nAA incorporation
and thus produce sfGFP. (B) Alternate versions of the new SubSeq DNA cassette for donating TAG. The two
alternatives are shown in the red boxes at the far left. (C) The two nAAs used in this study, p-azido-L-
phenylalanine (azF) and p-iodo-L-phenylalanine (iodoF).
doi:10.1371/journal.pone.0127504.g001
Directed Evolution with Non-Canonical Amino Acids
PLOS ONE | DOI:10.1371/journal.pone.0127504 May 26, 2015 3 / 18
production through endogenously expressed TEV. We demonstrate the approach using two
proteins, cytochrome b562 (cyt b562) and keratinocyte growth factor (KGF). Modification by
SPAAC with a fluorescent dye was achievable for only certain cyt b562 residues that were buried
in the native, non-mutagenized structure.
Materials and Methods
Materials
AzF and iodoF were purchased from Bachem and dissolved in 0.25 M NaOH prior to use.
DBCO-585 was purchased from Click Chemistry Tools and dissolved in DMSO to a stock con-
centration of 2.5 mM.
Fusion plasmid construction
The pET-22b(+) vector (Novagen/Merck) formed the basis for constructing pIFtag, with the
gene of interest expressed as a fusion with sfGFP under control of the T7 promoter. The two
fused proteins are separated via a TEV protease sequence (Fig 2B and S1 Fig). In this study ei-
ther cyt b562 or KGF were used as the N-terminal fusions to sfGFP. This plasmid was initially
constructed by splicing PCR amplified fragments containing either the mature portion of the
cybC gene (primers 109/112) or sfGFP (primers 104/105) via a linker encoding a new XhoI rec-
ognition site and the TEV cleavage site. NdeI and SalI sites were added to the 5’ and 3’ ends of
the fragment, respectively. The resulting fragment was ligated into the NdeI/XhoI sites in pET-
22b(+), thereby destroying the XhoI site within pET-22b(+), but adding an additional XhoI
site 5’ of the TEV cleavage site. Alternative genes of interest can be easily sub-cloned into this
vector upstream of the TEV site and sfGFP gene using NdeI/XhoI.
The 3 mutants, cg-51TAG/51Naa, cg-51TAG+1/CG-51Ile and cg-51TAG+2/CG-51Asn, whereby a
TAG codon was either added in-frame or +1 or +2 nucleotides with respect to K51 was
achieved by site-directed mutagenesis. Primer pairs 092/093, 092/102 and 092/103 were used
Fig 2. Selection for in-frame TAG replacement. (A) Schematic of the cytochrome (red) and sfGFP (green)
fusion with the TEV cleavage site between the two shown. The residue targeted (K51) for replacement and
the rational TAG replacements are shown. (B) cellular fluorescence of each variant in the absence (-nAA) and
presence (+nAA) of either azF or iodoF. The wt refers to the cyt b562-sfGFP fusion without any TAG codon
replacement. (C) SDS-PAGE (top panel) andWestern blot (bottom panel) analysis of fusion protein
expression in the soluble fraction of the cell lysate. The—v lane represents cells producing CG-wt in the
absence of the pAB vector. The + and—lanes refer to the presence or absence of the nAA, respectively. CG
and G refer to the cyt b562-sfGFP fusion (~40 kDa) and the sfGFP alone (27 kDa) generated through TEV
cleavage. TheWestern blot detection was performed with an antiGFP primary antibody.
doi:10.1371/journal.pone.0127504.g002
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to generate each respective TAG mutation. The mutations were confirmed by DNA sequenc-
ing. All primers sequences are listed in S1 Table.
Western blotting
E. coli Tuner cells hosting the pAB and pIFtag were grown in LB broth supplemented with
100 μg/ml ampicillin and 34 μg/ml chloramphenicol. The pAB plasmid harbours the iodoF
aminoacyl-tRNA-synthetase (aaRSiodoF) and two tRNACUA required for nAA incorporation
during cellular protein synthesis (S1 Fig). The aaRSiodoF is promiscuous and can be used for
high efficiency and fidelity incorporation of both iodoF and azF [15]. Protein production was
induced with 100 μM IPTG, and culture medium supplemented with 5 mM p-iodoPhe. Cells
were then incubated at 37°C with shaking overnight. Cells were collected and resuspended at
an OD600 of 10 in BugBuster (1 ml), 200 μg/ml lysozyme and benzonase (0.5 μl/1 ml BugBus-
ter) and incubated at room temperature for 30 min. Following fractionation by centrifugation
(20 min, 16000 g, 4°C) 10 μl of soluble fraction was analysed on a 15% SDS-PAGE alongside
NEB prestained protein marker. Proteins were blotted and detected with anti-GFP antibody
(1:10,000) and 2° antibody (1:10,000). Detection was performed using the BioRad Immun-Blot
AP Colorimetric Kit.
Library construction: cyt b562
The initial cyt b562 library was constructed in the plasmid pNOM [25] plasmid essentially as
described previously [21, 23]. Introduction of the MuDel transposon throughout the pNOM:
cybC plasmid was performed using MuA and generated ~4.3x104 cfu on transforming E. coli.
The colonies were pooled and plasmid DNA isolated. Replacement of MuDel by SubSeqTAG/CTA
in the vector was achieved by digestion of the plasmid pool with MlyI to remove MuDel and 3 bp
from the host plasmid, followed by dephosphorylation, purification following agarose gel electro-
phoresis, and ligation with the SubSeqTAG or SubSeqCTA cassette DNA. Transformation of E. coli
DH5α resulted in ~2.3 x104 CFU, with ~55% incorporating SubSeqTAG (~1.3x104 CFU) and 45%
SubSeqCTA (1.0x104 CFU), as calculated from individual transformations. The colonies were
pooled and a second digestion with MlyI removed SubSeq. Intramolecular ligation of digested
vector gave ~8.7 x104 CFU following transformation of E. coliDH5α.
The cybCTAG library was sub-cloned into a modified version of pIFtag (S1 Fig) between the
NcoI and XhoI sites upstream of encoded TEV cleavage site and sfGFP. Modified pIFtag has
the more amenable NcoI restriction site in place of NdeI but is otherwise identical to that in S1
Fig. It was necessary to use PCR on this occasion to add the relevant 5’NcoI recognition se-
quence. The library was amplified using Phusion High-Fidelity DNA Polymerase and primers
131 and 111 in 16 separate tubes for 20 cycles before subcloning into modified pIFtag.
Transformation of E. coliDH5α gave ~5.0x103 CFU, which were pooled and plamid DNA
isolated. The pooled pIFtag DNA was then used to transform electrocompetent E. coli Tuner
cells already containing pAB (S1 Fig). Colony fluorescence was determined using a transillumi-
nator. Non-fluorescent colonies (192 selected at random) were transferred to 96-well microtitre
plates and replica plated onto rectangular agar plates containing chloramphenicol (34 μg/ml),
carbenicillin (100 μg/ml), IPTG (100 μM) and iodoF (2 mM). After 24 hrs the plates were moved
to 4°C. Colonies that became fluorescent in the presence of iodoF were sequenced. All sequenced
variants contained in-frame TAG codons and variants covered ~15% of the cybC gene.
Library construction: KGF
DNA encoding codon-optimized keratinocyte growth factor (kgf) lacking a termination codon
was subcloned from pBMH (Biomatik) to pNOM-XP6 [34, 35] via NcoI and XhoI sites.
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Transposition of MuDel into pNOM-XP6:kgf using MuA for either 4 hours or overnight
yielded approx. 2.0x104 cfu after transformation into E. coli BL21 Gold (DE3) electrocompetent
cells. Following transformation, cells were plated on LB agar containing chloramphenicol
(34 μg/ml) and cells scrapped from the plate and pooled. DNA was purified from the pooled
cells and digested with NcoI and XhoI. The band corresponding to MuDel incorporated within
the kgf gene (~1.7 kb) was isolated and ligated with pNOM-XP6 also digested with NcoI/XhoI.
The resulting sample was used to transform E. coli BL21 Gold and yielded 1.3 x104 cfu. MuDel
was removed from kgf using MlyI and replaced by SubSeqTAG and SubSeqCTA. Subsequent liga-
tion and transformation resulted in 2.4 x104 variants selected on kanamycin containing LB
agar plates. SubSeq was excised via MlyI digestion and the remaining vector was recircularised
via intramolecular ligation. Subsequent transformation of E. coli DH5α resulted in more than
1.5 x106 cfu when selected on LB agar plates supplemented with 100 μg/ml carbenicillin. The
resulting library DNA was digested with NcoI/XhoI and subcloned into modified pIFtag. E.
coli BL21 Gold (DE3) cells containing pAB were transformed and plated on LB agar plates con-
taining 100 μg/ml ampicillin, 34 μg/ml chloramphenicol and 200 μM IPTG. A total of 77 non-
fluorescent colonies were transferred to 96-well format and replica plated onto LB agar con-
taining 100 μg/ml carbenicillin, 34 μg/ml chloramphenicol and 2 uM IPTG plus 2 mM azF,
and incubated at 30°C overnight. The sequence of 16 colonies that were non-fluorescent in the
absence of nAA and fluorescent in the presence were determined.
Protein production
E. coli BL21 Gold (DE3) cells were used to produce cyt b562 or KGF incorporating azF in re-
sponse to the amber (TAG) stop codon using a reprogrammed genetic code system similar to
that described previously [23, 36]. Cells were co-transformed with the relevant pIFtag plasmid
housing either the cyt b562 or KGF gene and pAB. Single colonies grown on ampicillin and
chloramphenicol LB agar were used to inoculate 1 mL LB broth cultures supplemented with
the same antibiotics. After 6 hours of growth at 37°C, the 1 mL cultures were used to inoculate
10 mL LB supplemented with ampicillin and chloramphenicol. Cultures were grown at 37°C
with shaking until an OD600 of 0.4–0.8 was achieved then 2.5 mM azF was added and the cul-
tures grown for a further hour. Protein expression was induced by the addition of 500 μM
IPTG for cyt b562-TAG variants or 100 μM IPTG for KGF-TAG variants and incubated at 37°C
for 24 hours. Cells were harvested by centrifugation and lysed in 50 mM Tris-HCl, pH 8.0,
150 mMNaCl containing 0.2 mg/mL lysozyme, 1 mM PMSF and 1 mM EDTA by sonication.
Strain-Promoted Azide-Alkyne Cycloaddition (SPAAC)
SPAAC reactions were performed, as described elsewhere [32], using crude cell lysates (to
mimic intracellular conditions more closely) as the source of azF-Cyt b562 or azF-KGF. SPAAC
was performed using cell lysates from 5 mL expression cultures standardised to an A600 of 1.
Reactions were performed with 5 μM of DBCO-585 at 25°C for 24 hours.
Fluorescent SDS-PAGE Analysis
SPAAC reactions were analysed using fluorescent imaging after SDS-PAGE. The reaction com-
ponents were separated by 20% SDS-PAGE using established protocols. Gel bands were imaged
and analysed using a Typhoon 9400 Variable Mode Imager with a 532 nm excitation laser and
a 610 nm emission filter with a 30 nm band pass. Images were processed using ImageJ software.
SDS-PAGE gels were subsequently stained with Coomassie Blue stain (50% (v/v) methanol,
10% (v/v) acetic acid, 0.1% (w/v) R250 Coomassie blue) and imaged to view all proteins.
Directed Evolution with Non-Canonical Amino Acids
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In silicomodelling of azF containing cyt b562 variants
Structure files for iron protoporphyrin IX were made using Avogadro [37]. Force field parame-
ters were derived based on the electrostatic model approach, which uses electrostatic potential
(ESP) to describe the electronic structure of the porphyrin [38]. Geometry optimization and
ESP calculations were performed using GAMESS-US [39] at the HF/6-31G level in order to be
consistent with the AMBER99sb force field [40]. The published crystal structure for holo-cyt
b562 (PDB code: 256B [41]) was used as the starting point for simulation of both proteins. For
the P45azF cyt b562 variant the published structure for apo-cyt b562 (PDB code: 1APC [42]) was
used instead. The structures were altered using a python script within MacPyMol to mutate the
chosen residue to azF prior to energy minimisation, which was carried out using the GRO-
MACS software package [43]. Molecular dynamic simulations were carried out using the
AMBER99sb force field, modified with the parameters for iron protoporphyrin IX and azF.
The starting structure was placed within a triclinic box with dimension of 6.4x6.1x7.8 nm. This
was populated using the SPC water model to solvate the system to a total number of 16986 sol-
vent molecules. The system was first energy minimised by performing 500 steps of steepest de-
scent method followed by 500 steps of Conjugant Gradient method. The lowest energy state of
the system was used as the starting conformation for the molecular dynamics simulation. The
simulations were conducted at a constant temperature and pressure of 300 K and 1 atm (NPT).
A cutoff of 8Å was chosen for nonbonded interactions and long range electrostatic interactions
were characterised using the Particle Mesh Ewald (PME) [44]. The simulations were carried
out for a total of 2 ns with a time step of 2 fs and the trajectories were analysed using various
GROMACS components and visualised using VMD [45] (www.ks.uiuc.edu/Research/vmd/).
Results and Discussion
In-frame TAG selection process
The general approach for selecting in-frame TAG codons required for nAA incorporation is
outlined in Fig 1A. TAG replacement in a target gene using the TriNEx process has been de-
scribed previously [23]. However, there was no easy way to determine in-frame and correctly
orientated TAG codons. To address this problem and to make the method more general in its
application, a new plasmid system was constructed (S1 Fig). The vector pIFtag housed the
sfGFP gene within the cloning site to allow direct gene fusion downstream of the target protein
bridged by a TEV protease sequence. The pAB vector was based on pAA [46] but housed two
additional elements. The first is a gene encoding inducible and endogenous production of TEV
protease to allow for in situ cleavage of the target protein-sfGFP fusion to prevent any potential
adverse downstream effects of the fusion event. The second is the promiscuous p-iodo-L-phe-
nylalanine (iodoF) aminoacyl tRNA synthetase under the control of the promoter and termina-
tor from the endogenously expressed glnS gene (E.coli glutaminyl-tRNA synthetase). This
iodoF aminoacyl tRNA synthetase is known to efficiently encode incorporation of various
nAAs [15]. To maximise the number of clones with in-frame TAG codons, a new version of
the TAG donating DNA cassette (SubSeq [21, 23]) was generated which sampled the comple-
ment sequence (CTA) in case of reverse cassette insertion (Fig 1B).
By generating the TAG codon replacement library (Fig 1A, step 1) and placing it in the con-
text of pIFtag (and accompanied by pAB) allows selection due to nAA incorporation based on
cellular green fluorescence (Fig 1A, step 2). The initial phase is to remove any cross codon ex-
change events during trinucleotide exchange that may generate amino acid substitution muta-
tions by colony selection in the absence of nAA. Variants with an in-frame TAG codon will
generate truncated products within the target and no sfGFP. Out-of-frame TAG events will
Directed Evolution with Non-Canonical Amino Acids
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generate substitutions leading to translational read through to sfGFP resulting in cellular fluo-
rescence. Non-fluorescent colonies are retained for the second selection round in which the
presence of the nAA will result in its incorporation at the position dictated by the TAG codon.
Translational read through from the target gene to sfGFP will occur resulting in cellular fluo-
rescence. Variants that were non-fluorescent in the first selection round due to other undesir-
able mutational events will thus also be removed. While we have used colony picking to
separate fluorescence and non-fluorescent cells, automated and high throughput systems such
as FACS can be used to facilitate the process.
To test that the system can select for in-frame TAG codons, a set of site-directed mutants
were generated in the small electron transfer protein, cytochrome b562 (cyt b562; Fig 2A). Cyto-
chrome b562 is proving to be an important system for studying metalloprotein electron transfer
at the single molecule level, and as a novel molecular electronic [47–49], biosensing [50, 51]
and controlled assembly scaffold [52–55]. To facilitate its use for both fundamental and appli-
cative studies, optimal interfacing with non-biological materials is required, which will be
aided by the use of nAAs with suitable coupling chemistry. For example, incorporation of p-
azido-L-phenylalanine (azF; Fig 1D) can introduce new photochemical cross-linking and
bioorthogonal conjugation properties onto a target protein [31].
Cyt b562 placed in-frame with sfGFP and the two linked via the TEV protease cleavage se-
quence (Fig 2A) resulted in cells displaying an obvious green fluorescence phenotype (Fig 2B).
Replacement of the codon for Lys51 with TAG (cg-51TAG/CG-51nAA) gave a nAA-dependent cell
fluorescence phenotype; cellular fluorescence was only observed in the presence of a nAA in the
culture medium. Shifting the TAG codon +1 (cg-51TAG+1/CG-51Ile) or +2 (cg-51TAG+2/CG-51Asn)
nucleotides with respect to K51 did not instill a nAA-dependent green fluorescence phenotype
(Fig 2B); despite the native amino acid substitution mutations in cyt b562, read through to sfGFP
occurred as predicted. Both SDS-PAGE andWestern blot confirmed that protein was only pro-
duced in the presence of nAA for the in-frame TAG variant and that cellular production of TEV
protease gave rise to in situ cleavage of the sfGFP from cyt b562 (Fig 2C).
The transposon-based random TAG codon replacement approach was applied to cyt b562.
The exact details of each step used to generate the library are outlined in the Methods section.
Sequencing revealed that all the colonies with a green fluorescence phenotype only in the pres-
ence of iodoF had an in-frame TAG (Table 1). A total of 16 different variants were observed
spread across cyt b562. The observed mutations sampled a wide variety of structural and func-
tional aspects of cyt b562, including each helical element and their linking loops, residues with
different degrees of surface exposure and vicinity to the heme centre (Table 1). The observed
frequency of several variants was high (e.g. A29nAA & P56nAA) but is in keeping with previ-
ous work concerning the use of the MuDel transposon system [21, 25, 34]. While MuDel in-
serted across the whole breadth of a target gene, there are thought to be preferred insertion
sequences based on a consensus sequence, previously reported to be NPyG/CPuN [56]. Based
on sequencing generated from the data derived from this current study and libraries generated
as part of previous published work [50, 57] (S2 Fig) there does not appear to be an absolute
consensus sequence, but there does appear to be a higher proportion of G/C rich pentamer se-
quences. This suggests that MuDel may have a higher target site preference for G/C rich
stretches of DNA. The nature of the TAG codon replacement event varied as expected between
true codon and cross codon replacement. Only 4 variants could be categorically ascribed to a
cross codon event with only one resulting in a substitution mutation in an adjacent amino acid;
the other three resulted in silent mutations (Table 1).
Directed Evolution with Non-Canonical Amino Acids
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Bioconjugation of cyt b562 by SPAAC
The SPAAC reaction is outlined in Fig 3. Essentially, the azF acts as the protein embedded
azide component that can react orthogonally under biologically compatible conditions with an
activated alkyne (cyclooctyne) [29]. As the azide group is prerequisite for SPAAC reactions
and not present in any natural biomolecule, modification with a derivative harbouring an al-
kyne (CC) will be specific to defined residue position within the target protein amongst the
cellular milieu or in vitro. Several variants identified during TAG codon screening were as-
sessed for the reactivity of the introduced phenyl azide group to its alkyne partner (Fig 4A) that
sampled a wide variety of cyt b562 structural features. Dibenzylcyclooctyne (DBCO) housing
the strained ring alkyne group linked to the fluorescence rhodamine dye Texas red (here on in
termed DBCO-585) was used to test for residue conjugation ability and efficiency [32].
The 11 variants selected for further analysis were successfully expressed in the presence of
azF as indicated by the red-pink phenotype due to the production of full length holo cyt b562
(Fig 4B); little or no expression was apparent in the absence azF. The colour of cells expressing
Table 1. Sequence and characteristics of observed cyt b562 TAG replacement variants.
cyt b562 mutation Nucleotide change Freq Apo SASA (Å2) a Holo SASA (Å2) a Secondary structure c
K19N,A20nAA aaa-gcg! aaC-TAg 1 9 b 17 b Lp H1-H2
A20nAA aaa-gcg! aaa-TAG 3 9 b 17 b Lp H1-H2
A24nAA gcg-gcg! gcC-TAg 3 81 e 59 e H2
A29nAA gac-gcg! gac-TAg 12 3 b 1 b H2
P45nAA acg-ccg! acg-TAG 6 19 b 4 b Lp H1-310b
S52nAA aaa-tca! aaa-TAG 2 25 b 58 e Lp 310–H3
P53nAA tca-ccg! tca-TAG 8 100 e 104 e Lp 310–H3
P56nAA agc-ccg! agc-TAg 12 82 e 109 e H3
L68nAA att-ctg! atC-Tag 2 68 e 14 b H3
Q71nAA ggt-cag! ggC-TAg 6 78 e 39 pe H3
A75nAA gac-gcg! gac-TAg 2 22 pe 9 b H3
L78nAA aag-ctg! aag-TAG 4 17 pe 37 pe H3
K83nAA ggt-aaa! ggt-TAG 1 115 e 97 e Lp H3-H4
Q88nAA gcg-cag! gcg-TAG 1 84 e 31 pe H4
A91nAA gct-gca! gct-TAG 3 46 pe 2 b H4
Q103nAA cac-cag! cac-TAg 1 143 e 36 pe H4
a calculated solvent accessible surface area (SASA) using GETAREA (http://curie.utmb.edu/getarea.html) b, buried; pe, partially exposed; e, exposed.
b residue interacting with heme.
c H1, H2, H3 and H4 refers to helices 1, 2, 3 and 4 running from the N- to C-terminus, with Lp referring to the corresponding linking loops.
doi:10.1371/journal.pone.0127504.t001
Fig 3. SPAAC between genetically encoded azide (red sphere) within a protein (blue spheres) and an
activate alkyne (dibenzylcyclooctyne;DBCO). A triazole link is formed between the azide and
alkyne groups.
doi:10.1371/journal.pone.0127504.g003
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two variants, A29azF and A91azF, were different to the others; the A29AzF cell pellet was more
orange and A91azF brown. Both A29 and A91 lie close to each other in the protein close at the
opposite end of the protein from the haem binding pocket (Fig 4A). SDS-PAGE revealed that
TEV protease cleavage in situ was largely complete leaving free cyt b562 separate from sfGFP
(Fig 4C). One variant, A29AzF, appeared to be produced at a higher level than the others, as in-
dicated by the darker band equivalent to sfGFP (~27 kDa) and cyt b562 (~13 kDa).
To assess how placement within the protein affected the reactivity of the phenyl azide
group, conjugation with DBCO-585 was performed. Only two variants, A29azF and P45azF,
were modified to any extent with the DBCO-585 derivative in cell lysates (Fig 4C). The native
residues at both these positions are buried in the determined structures of apo and holo forms,
with P45 being close to the heme co-factor in the holo-form (Table 1). The higher apparent
brightness of the P45azF cyt b562 variant suggests it was modified to a greater extent even
though more A29azF cyt b562 protein was produced (Fig 4C). The maintenance of a coloured
phenotype suggests that both variants still retain the capacity to bind haem on
azF incorporation.
There does not appear to a simple correlation between residue position encoding azF, its rel-
ative solvent accessibility of the native residue, position in secondary structure and the ability
to undergo SPAAC when replaced by azF. Most of the observed azF containing cyt b562 vari-
ants involve replacement of an exposed or a partially exposed residue (in apo or holo cyt b562).
Overexpressed engineered cyt b562 is routinely produced as a mixture of apo and holo protein
[58], both of which are produced as soluble proteins, so it is pertinent to take into account both
these forms. Three residues replaced with azF have their original residues buried in both apo
and holo forms according to the determined structures (Table 1), two of which (A29 and P45)
are the only ones open to conjugation via SPAAC. A24 resides in the same helix (H2) as A29
with both residues separated by just over one helical turn and occupying similar positions in
Fig 4. Production and conjugation of cyt b562 azF-containing variants. (A) Schematic structure of cyt
b562 showing the residues substituted with azF. (B) Expression of cyt b562 variants housed in the pIFtag
plasmid in the presence (+azF) or absence (-azF) of azF. Cells successfully expressing functional cyt b562
display a red phenotype. (C) SDS-PAGE analysis of SPAAC conjugation. The top panel shows the
Coomassie Blue stained and the bottom is fluorescence imaging of the DBCO-585 moiety. CG, G and C refer
to cyt b562-sfGFP fusion, sfGFP and cyt b562, respectively. The lower band is unreacted DBCO-585. For the
sake of transparency, the samples Q88 and A91 were run on separate gels to the others and the resulting
images electronically linked to the other samples.
doi:10.1371/journal.pone.0127504.g004
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both the apo and holo cyt b562 structures. However, the A24 residue is exposed to the solvent
while A29 is buried: only when azF is incorporated at residue 29 can cyt b562 be modified. This
suggests that on replacement of A29 with the bulkier and longer azF, the side chain must at
least become partially accessible to the solvent in either the apo and/or holo form. In an at-
tempt to rationalise the effect of A29azF mutation, the variant was modelled in silico using the
holo-cyt b562 structure as a template. The putative molecular model of holo-cyt b562 [41, 59]
A29azF revealed that the phenyl azide may potentially exert a significant local structural effect
and the reactive azide component may become surface exposed (Fig 4A). Rather than the phe-
nyl azide pointing directly out to the solvent, the azide group may still be closely associated
with the protein surface. Thus the modelling suggests replacement of the buried A29 with azF
results in the critical reactive azide group becoming surface exposed without full exposure of
the side chain as a whole.
A similar modelling approach was taken to rationalise the effect of the P45azF. The putative
model of holo cyt b562 P45
azF suggested that haemmay block accessibility for the incoming
DBCO group (Fig 4B). The structure of apo-cyt b562 is known to be less structured around the C-
terminal helix H4 [42, 60], making accurate modelling more difficult. Nonetheless, given that
over-expressed cyt b562 is known to be a mix of holo and apo forms [58] modelling of the P45azF
based on the available NMR structure of apo protein was attempted. The putative apo cyt b562
model of the P45azF variant suggested that the azide group becomes surface accessible and thus
available for modification (Fig 5B). As with the A29azF model, the azide group and the phenyl
azide side chain as a whole remains closely associated with the protein surface. Such a close sur-
face association of the azide group was associated with the residues displaying the highest modifi-
cation efficiency by SPAAC in sfGFP suggesting that a fully protruding phenyl azide may not be
ideal [32]. Therefore, a key observation, at least in terms of SPAACmodification of protein em-
bedded phenyl azides, is that burial of the native residue should not be overlooked as potential
useful modification site and that positions likely to retain a degree of surface association on con-
version to azF may be the ideal in terms of selecting high efficiency modification sites. Given that
Click chemistry approaches like SPAAC are becoming more and more utilised, these observa-
tions may have wider implications in terms of the design of modification sites.
Application of TAG in-frame mutagenesis to KGF
One of area of significant potential is the development of protein-based biopharmaceuticals
through the defined and controlled modification with polymers and other useful agents [8, 62].
Fig 5. In silicomodelling of azF cyt b562 variants. (A) Models of the A29azF holo cyt b562. The mutated residue, azF29, is coloured in cyan at its carbon
atoms. The right hand panel is a close up surface view of the model. (B) Models of the P45azF apo and holo cyt b562 variant. The mutated residue, azF45, is
coloured green at its carbon atoms. Haem is represented as spheres. The models were based on the PDB coordinate files 265B (Holo) and 1APU (apo). The
figures where generated using PyMol [61].
doi:10.1371/journal.pone.0127504.g005
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Derivatising a protein with large chemical adducts such as PEG shields them from proteolytic
degradation and rapid removal from the body resulting in improved pharmacokinetics. How-
ever, most of the current approaches rely either on the inherent chemistry of the natural 20
amino acids (e.g. amine, carboxyl and sulfhydryl) or the introduction of terminal “modifica-
tion” tagging sequences. Such lack of specificity in terms of position within the protein can give
rise to unwanted heterogeneity of the modified protein sample and the site of modification
may not be optimal for maximising protein stability/activity. One way of overcoming such
problems is through the defined placement of nAAs with useful bioorthogonal and biocompat-
ible reactivity, such as azF [31].
Initially, a range of different non-antibody therapeutic proteins were screened for their suit-
ability for use with the sfGFP fusion library selection approach: (1) Keratinocyte growth factor
(KGF) fragment (Kepivance); (2) Ethropoietin (EPO); (3) Uricase (URI; Rasburicase); (4) As-
paraginase (ASP; Oncaspar); (5) Streptokinase (SK; Streptase). When cloned in-frame with
sfGFP all the selected proteins conferred a fluorescence phenotype on E. coli (Fig 6A) suggest-
ing that they will be compatible with the library screening approach. As a test for the system, li-
brary construction was focused on KGF as it was relatively small (139 amino acids) and
conferred the brightest green fluorescent phenotype on E. coli under our expression conditions.
The pharmaceutical version of KGF used here (sequence provided in S3 Fig), also known as
Palifermin [63], is a recombinant analogue of human KGF with the first 23 residues at the N-
terminal removed to improve stability. It stimulates keratinocyte growth in a variety of tissues
and aids patient recovery from chemotherapy.
Using a combination of the two phase negative (non-fluorescent clones in absence of azF)
and positive (fluorescent clones in the presence of azF) selection procedure, 13 different vari-
ants at the amino acid level were identified (Fig 6B). The requirement of the nAA for cellular
gene fluorescence was confirmed by culturing cells expressing variants in the presence and ab-
sence of azF, three of which are show in Fig 6C as representatives. Only in the presence of azF
Fig 6. In-frame TAG replacement of KGF. (A) Compatibly of various therapeutic proteins with the E. coli
sfGFP fusion screening approach. KGF, keratinocyte growth factor fragment; EPO, ethropoietin; URI,
Uricase; ASP+ Asparaginase with N-terminal signal pepetide sequence; ASP- Asparaginase lacking N-
terminal signal peptide sequence; SK, Streptokinase. The ‘con’ sample is the control cell sample. The
proteins shown are all fused to sfGFP via the TEV digestion sequence. (B) Sequence of observed KGF
variants. (C) azF-dependent expression of selected KGF-sfGFP variants. (D) Map of observed mutations on
the structure of KGF, including an indication of whether the native residue is surface exposed (blue spheres)
or buried (grey spheres) based on surface accessibility.
doi:10.1371/journal.pone.0127504.g006
Directed Evolution with Non-Canonical Amino Acids
PLOS ONE | DOI:10.1371/journal.pone.0127504 May 26, 2015 12 / 18
was a fluorescence phenotype observed. Mapping the observed residues onto the known struc-
ture of KGF (PDB 1QQK;[64]) revealed that all but 3 (L119azF, A166azF, L167azF) of the vari-
ants were equivalent to exchange of surface exposed residues for azF (Fig 6D). While the
current dogma suggests that surface exposure is critical as we have seen here and previously
[32], this is not a guarantee for efficient modification by SPAAC especially when the mutation
may result in a residue converting from buried to partially exposed. Thus, we did not ignore
their potential for modification by SPAAC at this stage.
Another important requirement is that both mutation and the subsequent modification will
not impede function by, for example, disrupting a key protein-protein interaction. KGF inter-
acts with its cognate receptor FGFR2 and triggers various signalling pathways that simulate
production of proteins required for cell growth and survival in epithelial cells [65]. There is
currently no structure available for KGF bound to its cognate receptor FGFR2 so the KGF was
modelled against the structurally analogous FGF10-FGFR complex (Fig 7A; 1EV2[66]). Analy-
sis of the model revealed that six variants incorporate azF at positions distant from the protein-
protein interface: E124, E135, L144, W156, L167 and P173. These variants together with two
others with azF incorporated at E141 and L189 located at the receptor interface were chosen to
assess their modification with DBCO-585 by SPAAC (Fig 7).
While attachment of sfGFP is supposed to aid solubility of attached proteins [33], all the
KGF fusion variants were expressed as insoluble fusion proteins (Fig 7B and S4 Fig). While
whole cells expressing the KGF-sfGFP were fluorescent suggesting that sfGFP matured (and
thus folded) correctly, all the fluorescence was observed in the insoluble pellet fraction after cell
lysis. The product size (~44 kDa) indicates that the insoluble KGF-sfGFP fusion was not
cleaved by TEV suggesting the requirement for a soluble product for successful cleavage. This
Fig 7. Production and SPAACmodification of KGF variants. (A) Superimposition of the KGF structure on
the homologous FGF10-FGFR complex. Yellow and red spheres represent residues contributing to or not
involved in the receptor interface. (B) Inherent sfGFP fluorescence of different cellular fractions (top two
panels) and SPAACmodification with DBCO-585 of each analysed variant.
doi:10.1371/journal.pone.0127504.g007
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is in contrast to the cyt b562 fusions that produced largely soluble protein fusions that were es-
sentially fully cleaved (Figs 2C and 3C). Despite insolubility and lack of fusion cleavage all
eight KGF-sfGFP variants were capable of SPAAC modification with DBCO-585. Apart from 2
(E141azF and L144azF), each KGF-sfGFP fusion variant was modified to a similar extent (Fig
7B). This is contrast to cyt b562 were only selected residues were modified. The insolubility cou-
pled with likely aggregation may in the case of KGF facilitate general modification. This may
be through, for example, the generation of local surface exposed hydrophobic regions in which
a population of azide groups may reside; local hydrophobic patches have been suggested to aid
SPAAC modification with DBCO [32], especially as the DBCO moiety is itself hydrophobic.
Conclusion
We have shown here a general method for introducing in-frame amber stop codons for the di-
rected evolution of proteins containing non-canonical amino acids. The link through to sfGFP
expression and fluorescence allows identification of in-frame TAG codon replacements, and
the in situ cleavage of predominantly soluble fusion products via TEV protease decouples
sfGFP from the target protein. While we have demonstrated codon replacement with TAG, the
method can be adapted for any of the emerging approaches for nAA incorporation (e.g. qua-
druplet codon systems [67, 68]) through changing the nature of the donating sequence in the
SubSeq element. The ability to modify proteins in a truly bioorthogonal and biocompatible
manner via SPAAC (and other nAA-dependent approaches [1]) has obvious benefits for both
in situ and in vitromodification of proteins for fundamental and technological purposes. How-
ever, as we have shown here and elsewhere [32] simply choosing a surface exposed residues
based on available structural information does not guarantee high efficiency modification. If
this is the case, then a new strategy for protein engineers may be available for use with azF or
other conjugation compatible nAAs and directed evolution may prove a fruitful manner by
which to identify residues amenable to these next generation protein modification approaches.
Supporting Information
S1 Fig. Plasmids maps of (A) pIFtag and (B) the companion plasmid pAB. The pIFtag plas-
mid is based on pET22 except that downstream of the standard NcoI/NdeI and XhoI cloning
site is the DNA sequencing encoding TEV digestion site and sfGFP. Cloning of a target gene
(here with the cytochrome b562 sequence as an example) between the NcoI and XhoI site will
put it in the same reading frame as the downstream elements. (B) The companion plasmid
pAB is based on pAA reported previously as stated in the main text. It contains the engineered
aminoacyl tRNA synthetase and tRNA for nAA incorporation as well as the T5 promoter driv-
en expression of TEV protease.
(TIFF)
S2 Fig. MuDel target site sequence analysis. A graphical representation of the frequency at
which nucleotides appear at one of the 5 positions of the target site duplication, introduced
during MuDel transposition. The graphical representation was produced using the WebLogo
application (http://weblogo.threeplusone.com) from 181 unambiguous unique sequences sam-
pled by MuDel from the TAG replacement library reported here together with TND and do-
main insertion libraries reported previously [69, 70]. The height of each simple at each of the 5
positions is relative to the observed frequency of a particular base.
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S3 Fig. DNA (lower case) and protein (upper case) sequence of KGF used in this study.
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S4 Fig. SDS PAGE analysis of the soluble and insoluble cell lysate fractions of the KGF-
sfGFP azF fusion variants. The band labelled K-G at ~44 kDa corresponds to the uncleaved
KGF-sfGFP fusion product. All samples were standardised to set cell density (OD at 600 nm of
1.0).
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S1 Table. Oligonucleotide primer sequences.
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